What We're Reading: Page 191
Industry reads hand-picked by our editors
Jun 19, 2020
-
The New York Times
Can a Billionaire’s Son Spend His Way to a House Seat in New York?
-
Bloomberg
Older Adults Struggle to Get Pfizer's $225,000-a-Year Heart Drug
-
Reuters
U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients
-
Bloomberg Law
Rush for generic go-ahead on novel drugs roils pharma industry
Jun 18, 2020
-
The Washington Post
Before the pandemic, top contractor received billions from government to help prepare the nation for biowarfare
-
STAT
How likely are kids to get Covid-19? Scientists see a ‘huge puzzle’ without easy answers
-
South China Morning Post
Can China win Covid-19 vaccine race with old school technology?
Jun 17, 2020
Jun 16, 2020
-
The New York Times
Most Coronavirus Tests Cost About $100. Why Did One Cost $2,315?
-
Science Translational Medicine
What Might Go Wrong
-
Xconomy
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug
-
STAT
What’s at stake for industry in the pharmaceutical Space Race for a Covid-19 vaccine
Jun 15, 2020
-
Wall Street Journal
New Rules for Covid Summer: Be Flexible and Vigilant
-
STAT
FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer
-
Science
Fifty-four scientists have lost their jobs as a result of NIH probe into foreign ties
-
The New York Times
The Pandemic Claims New Victims: Prestigious Medical Journals
Jun 12, 2020
-
The Washington Post
Hedge fund manager stands to profit on 'flip' of taxpayer-funded coronavirus drug
-
The Boston Globe
Novo Nordisk buys Waltham biotech Corvidia for $725 million
-
Reuters
Bottlenecks? Glass vial makers prepare for COVID-19 vaccine
-
STAT
MIT ends negotiations with Elsevier over research access dispute
Jun 11, 2020
-
The New York Times
In the W.H.O.'s Coronavirus Stumbles, Some Scientists See a Pattern
-
The Boston Globe
Verve raises another $63m to develop gene-editing treatment for heart disease
-
The Wall Street Journal
Hit Hard by Coronavirus, Russia Joins Global Race for a Vaccine